In February 2003, the World Health Organization (WHO) reported about 300 cases of a rapidly progressive respiratory illness in the Guangdong Province of China with five deaths. Over the next month, similar cases were reported from Hong Kong, Vietnam, Singapore, and Canada. By the end of the worldwide outbreak in July 2003, a total of 8096 cases were reported, with 774 deaths and a case-fatality rate of 9.6 percent.
A novel coronavirus was detected in specimens from a number of the patients with "severe acute respiratory syndrome" (SARS). This coronavirus was known as SARS coronavirus (SARS-CoV). Once another novel coronavirus emerged in 2019 and was designated SARS-CoV-2, SARS-CoV became known as SARS-CoV-1.
Microbiology - Virology
Coronavirus (SARS) PCR
Severe Acute Respiratory Syndrome RNA
Collection packs can be ordered by emailing LabInfo@cdhb.health.nz
Chilled (2 - 8 degrees Celsius)
The diagnosis of SARS is largely based on clinical criteria and the exclusion of other respiratory pathogens. This diagnostic test can assist with the laboratory confirmation of a probable SARS case.
This current PCR is very specific but lacks sensitivity and will not detect all SARS patients being investigated who are excreting coronavirus.
Detection of SARS coronavirus RNA. Reverse transcriptase PCR. Confirmation of positives by sequencing.
$118.05 (Exclusive of GST)
"*" indicates required fields